As assistant vice president of health outcomes, Gleason leads research into healthcare access, costs and outcomes, helping guide benefit strategies for payers and providers

Constant communication across the supply chain limits disruption when a drug is unavailable

A strategic deep dive into the latest trend report from Prime Therapeutics reveals how oncology spend is evolving across benefits and what it means for cancer care management

Effective: January 2021 Terms of use IF YOU ARE EXPERIENCING A MEDICAL EMERGENCY, DIAL 911 AND/OR SEEK IMMEDIATE ATTENTION FROM A HEALTH CARE PROVIDER. THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE....